Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_assertion type Assertion NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_head.
- NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_assertion description "[MDA-MB-231 and HCC 1806 tumors xenografted into nude mice were significantly inhibited by treatment with AEZS-108; doxorubicin at equimolar doses was ineffective.As compared to AEZS 108, the Disorazol Z - LHRH conjugate, AEZS-125, demonstrated an increased cytotoxicity in vitro in HCC 1806 and MDA-MB-231 TNBC; this was diminished by receptor blockade with synthetic LHRH agonist (triptorelin) pretreatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_provenance.
- NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_assertion evidence source_evidence_literature NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_provenance.
- NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_assertion SIO_000772 25410881 NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_provenance.
- NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_assertion wasDerivedFrom befree-2016 NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_provenance.
- NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_assertion wasGeneratedBy ECO_0000203 NP1238726.RAo7JFwazWQFUOuysUiPVcyIv5tja8RTPHttUXLSC6Nq8130_provenance.